News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Erman Akkus: First line treatment of metastatic Colorectal Cancer in older patients
Photo from Erman Akkus/X
Aug 31, 2024, 18:34

Erman Akkus: First line treatment of metastatic Colorectal Cancer in older patients

Erman Akkus, Medical Oncology Fellow at Ankara University Faculty of Medicine, shared on X:

“FOLFOX/Xelox + beva vs. 5FU/cape +beva in first line treatment of metastatic CRC in older patients.

Median age 80 and 79
•No difference in PFS, 10 vs 9.4 mo.
•No difference in OS, 19.7 vs 21.3 mo.
•grade ≥3 AEs 69% vs. 52%

~65% left sided and ~36% RAS WT.”

Erman Akkus

Oxaliplatin Added to Fluoropyrimidine/Bevacizumab as Initial Therapy for Unresectable Metastatic Colorectal Cancer in Older Patients: A Multicenter, Randomized, Open-Label Phase III Trial (JCOG1018)

Authors: Atsuo Takashima, Tetsuya Hamaguchi, Junki Mizusawa, Fumio Nagashima, Masahiko Ando, Hitoshi Ojima, Tadamichi Denda, Jun Watanabe, Katsunori Shinozaki, Hideo Baba, Masako Asayama, Seiji Hasegawa, Toshiki Masuishi, Ken Nakata, Shunsuke Tsukamoto, Hiroshi Katayama, Kenichi Nakamura, Haruhiko Fukuda, Yukihide Kanemitsu, Yasuhiro Shimada,
Erman Akkus

Source: Erman Akkus/X

For more posts by Erman Akkus, visit oncodaily.com
Atsuo Takashima cancer Erman Akkus Fumio Nagashima Haruhiko Fukuda Hideo Baba Hiroshi Katayama Hitoshi Ojima Jun Watanabe Junki Mizusawa Katsunori Shinozaki Ken Nakata Kenichi Nakamura Masahiko Ando Masako Asayama OncoDaily Oncology Seiji Hasegawa Shunsuke Tsukamoto Tadamichi Denda Tetsuya Hamaguchi Toshiki Masuishi Yasuhiro Shimada Yukihide Kanemitsu
Special Coverage
Blog
Dec 21, 2024, 11:30
Kyaw Thein: Tissue-Agnostic Drug Development in Cancer
Dialogues
Dec 21, 2024, 11:29
Beyond the Cancer Diagnosis: Dialogue with Marianne Arab, Hosted by Adrian Pogacian
Blog
Dec 21, 2024, 11:27
Aleix Prat: Carlos Fernandez de Larrea has been appointed as a Professor at the University of Barcelona
Blog
Dec 21, 2024, 11:25
Canadian Cancer Society - Natalie Wild's caregiver story
Blog
Dec 21, 2024, 11:24
Christy Brown: How many things can you dread more than 'your child has aggressive brain cancer?'
Blog
Dec 21, 2024, 11:18
Jose Fernando Moura: Pivotal SABCS24 summary hosted by Cancer Network
Blog
Dec 21, 2024, 11:18
Jérôme Salomon: President Macron, WHO Director-General and global health leaders inaugurate WHO Academy
Blog
Dec 21, 2024, 11:17
ChatGPT-Like AI Tool Promises to Speed Treatment Advances and Free Doctors’ Time by Matching Patients with Clinical Trials
Blog
Dec 21, 2024, 11:14
Mediamedic - Wenbin Zhou on Pyrotinib-based regimen in HER2-positive breast cancer
Blog
Dec 21, 2024, 11:12
Didier Verhoeven: Comparing survival in breast cancer in Belgian Breast Centres
Blog
Dec 21, 2024, 11:06
Every great journey has its finale - eCAN Joint Action
Drugs
Dec 21, 2024, 10:38
Hanna Foster: Market cap and Revenue of Cancer NGS Drugs providers in 2024